Total Payments
$442,002
2024 Payments
$115.48
Companies
14
Transactions
80
Medicare Patients
2,118
Medicare Billing
$103,328
Payment Breakdown by Category
Consulting$228,660 (51.7%)
Other$211,000 (47.7%)
Food & Beverage$1,850 (0.4%)
Travel$492.62 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $228,660 | 28 | 51.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $193,500 | 15 | 43.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $15,000 | 1 | 3.4% |
| Honoraria | $2,500 | 1 | 0.6% |
| Food and Beverage | $1,850 | 33 | 0.4% |
| Travel and Lodging | $492.62 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Oyster Point Pharma, Inc. | $161,000 | 12 | $0 (2023) |
| Sight Sciences, Inc. | $120,791 | 15 | $0 (2024) |
| Ocular Therapeutix, Inc. | $82,540 | 10 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $40,914 | 13 | $0 (2021) |
| Alcon Research Ltd | $17,245 | 4 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $5,121 | 10 | $0 (2019) |
| Ivantis, Inc | $5,000 | 1 | $0 (2020) |
| EllexiScience | $2,500 | 1 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $2,500 | 1 | $0 (2017) |
| Alcon Laboratories Inc | $2,280 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $115.48 | 2 | Sight Sciences, Inc. ($115.48) |
| 2023 | $50,141 | 8 | Ocular Therapeutix, Inc. ($25,040) |
| 2022 | $196,575 | 15 | Oyster Point Pharma, Inc. ($136,000) |
| 2021 | $52,552 | 6 | Ocular Therapeutix, Inc. ($27,500) |
| 2020 | $70,049 | 11 | Ocular Therapeutix, Inc. ($30,000) |
| 2019 | $40,662 | 13 | Aerie Pharmaceuticals, Inc. ($35,182) |
| 2018 | $3,531 | 11 | EllexiScience ($2,500) |
| 2017 | $28,377 | 14 | Alcon Research Ltd ($17,100) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Ophthalmology | ||||||
| 05/06/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $98.99 | General |
| Category: Ophthalmology | ||||||
| 11/03/2023 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $40.04 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 08/01/2023 | Ocular Therapeutix, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| 07/13/2023 | Ocular Therapeutix, Inc. | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 05/09/2023 | Ocular Therapeutix, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 03/10/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: DRY EYE | ||||||
| 03/02/2023 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $100.98 | General |
| Category: Ophthalmology | ||||||
| 01/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| Category: DRY EYE | ||||||
| 01/17/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: DRY EYE | ||||||
| 10/06/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,000.00 | General |
| Category: DRY EYE | ||||||
| 10/01/2022 | NEW WORLD MEDICAL,INC. | Kahook Dual Blade (Device), Streamline Surgical System, Ahmed Glaucoma Valve | Food and Beverage | In-kind items and services | $50.88 | General |
| Category: Ophthalmology | ||||||
| 09/14/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Ophthalmology | ||||||
| 08/24/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| Category: Ophthalmology | ||||||
| 08/10/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $25,000.00 | General |
| Category: DRY EYE | ||||||
| 07/20/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $16,000.00 | General |
| Category: DRY EYE | ||||||
| 07/20/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,000.00 | General |
| Category: DRY EYE | ||||||
| 07/20/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,000.00 | General |
| Category: DRY EYE | ||||||
| 07/20/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,000.00 | General |
| Category: DRY EYE | ||||||
| 03/09/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Consulting Fee | Cash or cash equivalent | $37,500.00 | General |
| Category: Ophthalmology | ||||||
| 03/04/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Ophthalmology | ||||||
| 02/04/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,000.00 | General |
| Category: DRY EYE | ||||||
| 02/04/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,000.00 | General |
| Category: DRY EYE | ||||||
| 02/04/2022 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $15,000.00 | General |
| Category: DRY EYE | ||||||
| 01/12/2022 | Sight Sciences, Inc. | OMNI(R) SURGICAL SYSTEM (US) (Device) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 499 | 651 | $86,573 | $23,307 |
| 2022 | 7 | 474 | 607 | $89,463 | $24,895 |
| 2021 | 8 | 564 | 743 | $130,647 | $32,794 |
| 2020 | 8 | 581 | 649 | $93,702 | $22,332 |
Total Patients
2,118
Total Services
2,650
Medicare Billing
$103,328
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 90 | 180 | $38,520 | $11,086 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 96 | 146 | $21,608 | $6,153 | 28.5% |
| 92133 | Imaging of optic nerve | Facility | 2023 | 142 | 146 | $10,512 | $2,030 | 19.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 18 | 18 | $5,274 | $1,819 | 34.5% |
| 92083 | Exam of visual field with extended testing | Facility | 2023 | 94 | 102 | $7,854 | $1,631 | 20.8% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2023 | 33 | 33 | $1,947 | $444.31 | 22.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Facility | 2023 | 26 | 26 | $858.00 | $144.48 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 156 | 280 | $59,920 | $17,715 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 38 | $5,624 | $1,956 | 34.8% |
| 92133 | Imaging of optic nerve | Facility | 2022 | 136 | 138 | $9,936 | $1,845 | 18.6% |
| 92083 | Exam of visual field with extended testing | Facility | 2022 | 90 | 97 | $7,469 | $1,648 | 22.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $4,688 | $1,305 | 27.8% |
| 92020 | Exam of the internal drainage system of eye | Facility | 2022 | 22 | 22 | $1,298 | $328.69 | 25.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Facility | 2022 | 16 | 16 | $528.00 | $98.22 | 18.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 191 | 351 | $73,674 | $22,658 | 30.8% |
| 65855 | Laser repair to improve eye fluid flow, 1 or more sessions | Facility | 2021 | 18 | 18 | $25,984 | $3,580 | 13.8% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Facility | 2021 | 123 | 137 | $10,549 | $2,211 | 21.0% |
| 92133 | Diagnostic imaging of optic nerve of eye | Facility | 2021 | 158 | 163 | $11,457 | $2,159 | 18.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 27 | 27 | $3,740 | $1,011 | 27.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 12 | 12 | $3,516 | $854.38 | 24.3% |
| 92020 | Examination of cornea and iris using lens device and slit lamp | Facility | 2021 | 22 | 22 | $1,298 | $270.64 | 20.9% |
| 76514 | Ultrasound of corneal structure and measurement | Facility | 2021 | 13 | 13 | $429.00 | $50.00 | 11.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 146 | 167 | $29,726 | $8,395 | 28.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 136 | 172 | $19,952 | $5,716 | 28.6% |
| 65855 | Laser repair to improve eye fluid flow, 1 or more sessions | Facility | 2020 | 13 | 14 | $19,488 | $2,433 | 12.5% |
About Dr. Anthony Realini, M.D
Dr. Anthony Realini, M.D is a Ophthalmology healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437127404.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Realini, M.D has received a total of $442,002 in payments from pharmaceutical and medical device companies, with $115.48 received in 2024. These payments were reported across 80 transactions from 14 companies. The most common payment nature is "Consulting Fee" ($228,660).
As a Medicare-enrolled provider, Realini has provided services to 2,118 Medicare beneficiaries, totaling 2,650 services with total Medicare billing of $103,328. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Morgantown, WV
- Active Since 03/08/2006
- Last Updated 04/12/2022
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1437127404
Products in Payments
- TYRVAYA (Drug) $161,000
- OMNI(R) SURGICAL SYSTEM (US) (Device) $85,524
- DEXTENZA (Drug) $57,540
- OMNI (Device) $35,050
- Hydrus (Device) $5,000
- VYZULTA (Drug) $2,526
- Rhopressa (Drug) $804.40
- Ahmed Glaucoma Valve (Device) $515.20
- OMNI SURGICAL SYSTEM (Device) $216.46
- SIMBRINZA (Biological) $151.29
- CyPass (Device) $144.88
- Kahook Dual Blade (Device) $50.88
- ACTHAR (Biological) $18.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Morgantown
Dr. John Nguyen, Md, MD
Ophthalmology — Payments: $100,920
Ophthalmology $100,920
Dr. Mark Mayle, M.d, M.D
Ophthalmology — Payments: $7,793
Ophthalmology $7,793
Brian Mcmillan
Ophthalmology — Payments: $7,451
Ophthalmology $7,451
Dr. Jennifer Sivak-Callcott, M.d, M.D
Ophthalmology — Payments: $7,224
Ophthalmology $7,224
Dr. Nabil Jabbour, M.d, M.D
Ophthalmology — Payments: $7,137
Ophthalmology $7,137
Dr. Edgar Gamponia, M.d, M.D
Ophthalmology — Payments: $3,346
Ophthalmology $3,346